LINC02192

Across TCGA pan-cancer cohorts, LINC02192 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of LINC02192’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where LINC02192 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02192 is over-expressed in tumor, although a few such as KIRC and KICH show the opposite, repressed pattern.

HNSC, KIRC, and LUAD are the cancer types where LINC02192 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02192 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	II,III,IV	+0.045	.009	6	view →
KIRC	All	All	−0.021	.007	4	view →
LUAD	All	All	+0.102	.007	3	view →
KICH	All	All	−0.054	.003	3	view →
PAAD	Female	All	−0.075	.037	2	view →
KIRP	All	All	−0.033	.004	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

LINC02192–HNSC

Open the HNSC breakdown →